Twist Bioscience (TWST) Stock Forecast & Price Target

Compare

983 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TWST Analyst Ratings

Moderate Buy

7 Buy

1 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Twist

Bioscience

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TWST Stock 12 Month Forecast

Average Price Target

$47.75

▲(57.43%Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Twist Bioscience in the last 3 months. The average price target is $47.75 with a high forecast of $62.00 and a low forecast of $33.00. The average price target represents a 57.43% change from the last price of $30.33.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"30":"$30","63":"$63","38.25":"$38.3","46.5":"$46.5","54.75":"$54.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$62.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":47.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$47.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$33.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[30,38.25,46.5,54.75,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.71,39.57846153846154,41.44692307692308,43.315384615384616,45.183846153846154,47.05230769230769,48.92076923076923,50.78923076923077,52.65769230769231,54.526153846153846,56.394615384615385,58.26307692307692,60.13153846153846,{"y":62,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.71,38.48230769230769,39.254615384615384,40.026923076923076,40.79923076923077,41.57153846153846,42.34384615384616,43.11615384615385,43.88846153846154,44.66076923076923,45.433076923076925,46.20538461538462,46.97769230769231,{"y":47.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.71,37.347692307692306,36.98538461538462,36.62307692307692,36.260769230769235,35.89846153846154,35.536153846153844,35.173846153846156,34.81153846153846,34.449230769230766,34.08692307692308,33.72461538461538,33.362307692307695,{"y":33,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":34.41,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.96,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.9,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.93,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.05,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.24,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.57,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.3,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.37,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.82,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.94,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.71,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$62.00

Average Price Target$47.75

Lowest Price Target$33.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$34

Hold

12.10%

Upside

Reiterated

05/07/25

Twist Bioscience's overall score reflects strong revenue growth and strategic corporate decisions, offset by ongoing profitability challenges and technical indicators showing bearish momentum. The negative valuation metrics further weigh on the score, although positive earnings call sentiment and corporate events provide some optimism.

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$54→$44

Buy

45.07%

Upside

Reiterated

05/06/25

Twist Bioscience price target lowered to $44 from $54 at BairdTwist Bioscience price target lowered to $44 from $54 at Baird

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$33

Sell

8.80%

Upside

Reiterated

05/06/25

Cautious Outlook on Twist Bioscience Amidst Macroeconomic Challenges and Premium Valuation

Sung Ji NamScotiabank

Scotiabank

$62

Buy

104.42%

Upside

Reiterated

05/06/25

Scotiabank Remains a Buy on Twist Bioscience (TWST)

Matt LarewWilliam Blair

William Blair

―

Buy

―

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF), BioMarin Pharmaceutical (NASDAQ: BMRN) and Twist Bioscience (NASDAQ: TWST)

Brendan SmithTD Cowen

TD Cowen

$58

Buy

91.23%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Ardelyx (NASDAQ: ARDX) and Twist Bioscience (NASDAQ: TWST)

Luke SergottBarclays

Barclays

$45

Buy

48.37%

Upside

Reiterated

05/05/25

Barclays on Twist Bioscience (TWST): recommend buy the dipsBarclays analyst Luke Sergott reiterated an Overweight rating and $45.00 price target on Twist Bioscience (NASDAQ: TWST)

Puneet SoudaLeerink Partners

Leerink Partners

$40

Hold

31.88%

Upside

Reiterated

05/05/25

Leerink Partners reiterates Market Perform Rating on Twist Bioscience (TWST)Leerink Partners analyst Puneet Souda reiterated a Market Perform rating and $40.00 price target on Twist Bioscience (NASDAQ: TWST)

Unknown AnalystEvercore ISI

Not Ranked

Evercore ISI

$52→$50

Buy

64.85%

Upside

Reiterated

05/05/25

Twist Bioscience (TWST) PT Lowered to $50 at Evercore ISIEvercore ISI analyst Ross Muken lowered the price target on Twist Bioscience (NASDAQ: TWST) to $50.00 (from $52.00) while maintaining a Outperform rating.

Subbu NambiGuggenheim

Guggenheim

$58→$50

Buy

64.85%

Upside

Reiterated

03/28/25

Twist Bioscience price target lowered to $50 from $58 at GuggenheimTwist Bioscience price target lowered to $50 from $58 at Guggenheim

Doug SchenkelWolfe Research

Wolfe Research

$60

Buy

97.82%

Upside

Initiated

12/13/24

Twist Bioscience initiated with an Outperform at Wolfe ResearchTwist Bioscience initiated with an Outperform at Wolfe Research

Matthew SykesGoldman Sachs

Goldman Sachs

$45→$55

Buy

81.34%

Upside

Reiterated

07/08/24

Twist Bioscience (TWST) PT Raised to $55 at Goldman SachsGoldman Sachs analyst Matthew Sykes raised the price target on Twist Bioscience (NASDAQ: TWST) to $55.00 (from $45.00) while maintaining a Buy rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$34

Hold

12.10%

Upside

Reiterated

05/07/25

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$54→$44

Buy

45.07%

Upside

Reiterated

05/06/25

Twist Bioscience price target lowered to $44 from $54 at BairdTwist Bioscience price target lowered to $44 from $54 at Baird

Rachel VatnsdalJ.P. Morgan

J.P. Morgan

$33

Sell

8.80%

Upside

Reiterated

05/06/25

Cautious Outlook on Twist Bioscience Amidst Macroeconomic Challenges and Premium Valuation

Sung Ji NamScotiabank

Scotiabank

$62

Buy

104.42%

Upside

Reiterated

05/06/25

Scotiabank Remains a Buy on Twist Bioscience (TWST)

Matt LarewWilliam Blair

William Blair

―

Buy

―

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (Other OTC: ANDHF), BioMarin Pharmaceutical (NASDAQ: BMRN) and Twist Bioscience (NASDAQ: TWST)

Brendan SmithTD Cowen

TD Cowen

$58

Buy

91.23%

Upside

Reiterated

05/05/25

Analysts Offer Insights on Healthcare Companies: Ardelyx (NASDAQ: ARDX) and Twist Bioscience (NASDAQ: TWST)

Luke SergottBarclays

Barclays

$45

Buy

48.37%

Upside

Reiterated

05/05/25

Barclays on Twist Bioscience (TWST): recommend buy the dipsBarclays analyst Luke Sergott reiterated an Overweight rating and $45.00 price target on Twist Bioscience (NASDAQ: TWST)

Puneet SoudaLeerink Partners

Leerink Partners

$40

Hold

31.88%

Upside

Reiterated

05/05/25

Unknown AnalystEvercore ISI

Not Ranked

Evercore ISI

$52→$50

Buy

64.85%

Upside

Reiterated

05/05/25

Subbu NambiGuggenheim

Guggenheim

$58→$50

Buy

64.85%

Upside

Reiterated

03/28/25

Twist Bioscience price target lowered to $50 from $58 at GuggenheimTwist Bioscience price target lowered to $50 from $58 at Guggenheim

Doug SchenkelWolfe Research

Wolfe Research

$60

Buy

97.82%

Upside

Initiated

12/13/24

Twist Bioscience initiated with an Outperform at Wolfe ResearchTwist Bioscience initiated with an Outperform at Wolfe Research

Matthew SykesGoldman Sachs

Goldman Sachs

$45→$55

Buy

81.34%

Upside

Reiterated

07/08/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Twist Bioscience

1 Month

xxx

Success Rate

6/12 ratings generated profit

Average Return

+3.02%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.02% per trade.

3 Months

xxx

Success Rate

8/12 ratings generated profit

Average Return

+0.42%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +0.42% per trade.

1 Year

Rachel VatnsdalJ.P. Morgan

Success Rate

8/12 ratings generated profit

Average Return

-14.32%

reiterated a sell rating last month

Copying Rachel Vatnsdal's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -14.32% per trade.

2 Years

xxx

Success Rate

7/12 ratings generated profit

Average Return

-22.66%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of -22.66% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TWST Analyst Recommendation Trends

Rating

Dec 24

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TWST has received 9 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. TWST average Analyst price target in the past 3 months is 47.75.

Each month's total comprises the sum of three months' worth of ratings.

TWST Financial Forecast

TWST Earnings Forecast

Next quarter’s earnings estimate for TWST is -$0.52 with a range of -$0.61 to -$0.40. The previous quarter’s EPS was -$0.66. TWST beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year TWST has Outperformed its overall industry.

TWST Sales Forecast

Next quarter’s sales forecast for TWST is $95.41M with a range of $94.00M to $96.39M. The previous quarter’s sales results were $92.79M. TWST beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year TWST has Outperformed its overall industry.

TWST Stock Forecast FAQ

What is TWST’s average 12-month price target, according to analysts?

Based on analyst ratings, Twist Bioscience Corp’s 12-month average price target is 47.75.

What is TWST’s upside potential, based on the analysts’ average price target?

Twist Bioscience Corp has 57.43% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TWST a Buy, Sell or Hold?

Twist Bioscience Corp has a consensus rating of Moderate Buy which is based on 7 buy ratings, 1 hold ratings and 1 sell ratings.

What is Twist Bioscience Corp’s price target?

The average price target for Twist Bioscience Corp is 47.75. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $62.00 ,the lowest forecast is $33.00. The average price target represents 57.43% Increase from the current price of $30.33.

What do analysts say about Twist Bioscience Corp?

Twist Bioscience Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of TWST?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Twist Bioscience (TWST) Stock Forecast & Price Target

TWST Analyst Ratings

TWST Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Twist Bioscience

TWST Analyst Recommendation Trends

TWST Financial Forecast

TWST Earnings Forecast

TWST Sales Forecast

TWST Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts